Sjs Investment Consulting Inc. Embecta Corp. Transaction History

Sjs Investment Consulting Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$15.0 - $22.17 $15 - $22	-1 Reduced 25.0%	3 $0
Q2 2023 Jul 13, 2023	BUY	$21.6 - $30.69 $43 - $61	2 Added 100.0%	4 $0
Q1 2023 Apr 20, 2023	SELL	$23.07 - $32.77 $69 - $98	-3 Reduced 60.0%	2 $0
Q4 2022 Jan 23, 2023	BUY	$25.29 - $35.48 $75 - $106	3 Added 150.0%	5 $0
Q3 2022 Oct 13, 2022	BUY	$24.0 - $33.42 $48 - $66	2 New	2 $0

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.